Summary
Bong Kwon is an Investment Principal with 11 years of experience specializing in venture capital and corporate business development across bio/healthcare, currently leading bio/healthcare investments at Mirae Asset Capital. He sources and structures deals across diagnostics, oncology, TPDs, ADCs, siRNA for CNS and BBB shuttle technologies, and recently helped form a new KRW 20 billion fund. Prior roles at Samsung Venture Investment, LG Chem Life Sciences and Daewoong combined strategic corporate partnerships, licensing and CVC fund formation, delivering exits and multi‑fold acquisitions. He serves on multiple boards and observerships, bringing hands‑on deal execution and scientific domain expertise from a Master of Pharmacy in pharmacology and medicinal chemistry. Less obvious: he routinely integrates commercial diligence with technical due diligence, bridging bench science and corporate strategy to accelerate translational assets.
11 years of coding experience
11 years of employment as a software developer
Master of pharmacy, pharmacology, Medicinal Chemistry, Master of pharmacy, pharmacology, Medicinal Chemistry at Kyung Hee University
English, Chinese, Korean